A specific model for the functional interaction of 75 kD (p75) and tyrosine kinase (trk) neurotrophin receptors will be tested. The model proposes that the functional form of p75 is dimeric, that dimerization is regulated by phosphorylation, that neurotrophins act upon p75 and trk receptors independently, that activation of p75 by neurotrophins follows the Monod model for concerted conformational transitions, and that the active conformation of p75 preferentially binds trk dimers, facilitating trk receptor dimerization and activation. Also, the possibility that p75 facilitates retrograde axonal signaling by regulating retrograde axonal transport of active neurotrophin/trk complexes will be examined. Binding studies and biochemical studies of p75 receptors expressed in various non-neuronal and neuronal cell lines will be performed to examine the relationship of receptor dimerization, phosphorylation, and positively cooperative neurotrophin binding, and relationship of these properties to the ability of p75 to enhance trk receptor activation will be examined. In vitro mutagenesis of p75, followed by expression in non- neuronal and neuronal cell lines, will be employed to define important structural elements involved in p75 function - particularly focusing on putative regulatory phosphorylation sites in the cytoplasmic domain, and a cysteinyl residue within the transmembrane domain which may be required for generation of functional receptor dimers. The effects of p75 on intracellular trafficking of endocytic vesicles bearing neurotrophins and trk receptors will be examined, in non-neuronal cells, and in axons of neurons in culture. Immunohistochemical techniques at the electron microscopic level will be performed to characterize the distribution of p75 and trk receptors among intracellular membrane pools. Confocal fluorescence microscopy, with pH-sensitive dyes, will be performed to determine the timing of acidification of endosomes within axons of chick embryo sympathetic and sensory axons in culture. This information, coupled with the results of examining the pH-dependence of neurotrophin binding to receptors, will reveal whether functionally active neurotrophin/receptor complexes may be transported intact from the nerve terminus to the neuronal cell body in order to convey retrograde trophic signals. These studies will characterize processes which are fundamental to the mechanisms by which neurotrophic factors shape the developing brain and peripheral nervous system, and by which regeneration of the injured nervous system is encouraged.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
1R01NS033200-01
Application #
2271848
Study Section
Neurology C Study Section (NEUC)
Project Start
1995-01-01
Project End
1997-12-31
Budget Start
1995-01-01
Budget End
1995-12-31
Support Year
1
Fiscal Year
1995
Total Cost
Indirect Cost
Name
University of Washington
Department
Physiology
Type
Schools of Medicine
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98195
Hatch, Nan E; Hudson, Mark; Seto, Marianne L et al. (2006) Intracellular retention, degradation, and signaling of glycosylation-deficient FGFR2 and craniosynostosis syndrome-associated FGFR2C278F. J Biol Chem 281:27292-305
Kanning, Kevin C; Hudson, Mark; Amieux, Paul S et al. (2003) Proteolytic processing of the p75 neurotrophin receptor and two homologs generates C-terminal fragments with signaling capability. J Neurosci 23:5425-36
Burke, Melanie A; Bothwell, Mark (2003) p75 neurotrophin receptor mediates neurotrophin activation of NF-kappa B and induction of iNOS expression in P19 neurons. J Neurobiol 55:191-203
Iwamoto, Satori; Burrows, Robert C; Kalina, Robert E et al. (2002) Immunophenotypic differences between uveal and cutaneous melanomas. Arch Ophthalmol 120:466-70
Iwamoto, Satori; Burrows, Robert C; Grossniklaus, Hans E et al. (2002) Immunophenotype of conjunctival melanomas: comparisons with uveal and cutaneous melanomas. Arch Ophthalmol 120:1625-9
Hutson, L D; Bothwell, M (2001) Expression and function of Xenopus laevis p75(NTR) suggest evolution of developmental regulatory mechanisms. J Neurobiol 49:79-98
Iwamoto, S; Burrows, R C; Agoff, S N et al. (2001) The p75 neurotrophin receptor, relative to other Schwann cell and melanoma markers, is abundantly Expressed in spindled melanomas. Am J Dermatopathol 23:288-94
Gunther, E C; von Bartheld, C S; Goodman, L J et al. (2000) The G-protein inhibitor, pertussis toxin, inhibits the secretion of brain-derived neurotrophic factor. Neuroscience 100:569-79
Yuen, E C; Gunther, E C; Bothwell, M (2000) Nitric oxide activation of TrkB through peroxynitrite. Neuroreport 11:3593-7
Iwamoto, S; Burrows, R C; Born, D E et al. (2000) The application of direct immunofluorescence to intraoperative neurosurgical diagnosis. Biomol Eng 17:17-22